{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:11:01Z","timestamp":1792393861120,"version":"4.4.0"},"reference-count":15,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,1,2]],"date-time":"2009-01-02T00:00:00Z","timestamp":1230854400000},"content-version":"vor","delay-in-days":916,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Laryngoscope"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives:<\/jats:bold> Botulinum toxin type A (BtxA) has been reported to be feasible in chronic neuropathic pain after neck dissection. The impact of the dose on the outcome has not been investigated yet.<\/jats:p><jats:p><jats:bold>Study Design:<\/jats:bold> Twenty\u2010three patients with neuropathic pain after neck dissection were selected for an open and prospective phase II trial.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In the low\u2010dose group (n = 13), a concentration of 10 mouse units (MU)\/0.1 mL saline and in the high\u2010dose\u2010group (n = 10), a concentration of 20 MU\/0.1 mL saline were injected subcutaneously. Pain and quality of life were assessed at day 0 and day 28, respectively, by visual analog scales (VAS) and European Organization for Research and Treatment of Cancer (EORTC) quality\u2010of\u2010life core and EORTC quality\u2010of\u2010life head and neck module questionnaires.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Patients in the low\u2010dose group showed a significant pain reduction (VAS) from 4.3 at day 0 to 3.0 at day 28 (<jats:italic>P<\/jats:italic> &lt; .05). The mean pain VAS values in the high\u2010dose group did not improve significantly. No serious adverse events were observed. There were trends toward improvement in quality of life in the low\u2010dose group.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> BtxA in a low concentration seems to be a useful therapeutic option in chronic neuropathic pain of the neck and shoulder after neck dissection.<\/jats:p>","DOI":"10.1097\/01.mlg.0000217797.05523.75","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T19:17:58Z","timestamp":1152213478000},"page":"1168-1171","source":"Crossref","is-referenced-by-count":53,"title":["Botulinum Toxin A for Neuropathic Pain After Neck Dissection: A Dose\u2010Finding Study"],"prefix":"10.1002","volume":"116","author":[{"given":"Claus","family":"Wittekindt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei\u2010Chi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon F.","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando","family":"Guntinas\u2010Lichius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,2]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195209)5:5<873::AID-CNCR2820050504>3.0.CO;2-4"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20008"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(99)00054-8"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-1102-z"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92070-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2000.00066.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.10340"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhn.2000.104946"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01868"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00106-001-0587-3"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(99)00153-1"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","unstructured":"ChaddockJA.Retargeted clostridial endopeptidases: Inhibition of nociceptive neurotransmitter release in vitro and antinociceptive activity in in vivo models of pain. Mov Disord2004:Suppl 8:S42\u2013S47.","DOI":"10.1002\/mds.20008"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.1.80"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290407"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.64.1.13"}],"container-title":["The Laryngoscope"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1097%2F01.mlg.0000217797.05523.75","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/01.mlg.0000217797.05523.75","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:03:34Z","timestamp":1695618214000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/01.mlg.0000217797.05523.75"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1097\/01.mlg.0000217797.05523.75"],"URL":"https:\/\/doi.org\/10.1097\/01.mlg.0000217797.05523.75","archive":["Portico"],"relation":{},"ISSN":["0023-852X","1531-4995"],"issn-type":[{"value":"0023-852X","type":"print"},{"value":"1531-4995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}